US 6613764
Aspartic protease inhibitors
expired A61PA61P31/18
Quick answer
US patent 6613764 (Aspartic protease inhibitors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P31/18